EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular insights into GPCR mechanisms for drugs of abuse

Omar B Sanchez-Reyes, Gregory Zilberg, John D McCorvy, Daniel Wacker

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Omar B Sanchez-Reyes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Illicit Drugs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDA NIH HHS, McKnight Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance abuse is on the rise, and while many people may use illicit drugs mainly due to their rewarding effects, their societal impact can range from severe, as is the case for opioids, to promising, as is the case for psychedelics. Common with all these drugs' mechanisms of action are G protein-coupled receptors (GPCRs), which lie at the center of how these drugs mediate inebriation, lethality, and therapeutic effects. Opioids like fentanyl, cannabinoids like tetrahydrocannabinol, and psychedelics like lysergic acid diethylamide all directly bind to GPCRs to initiate signaling which elicits their physiological actions. We herein review recent structural studies and provide insights into the molecular mechanisms of opioids, cannabinoids, and psychedelics at their respective GPCR subtypes. We further discuss how such mechanistic insights facilitate drug discovery, either toward the development of novel therapies to combat drug abuse or toward harnessing therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledIllicit DrugsHumansAnalgesics, OpioidCannabinoidsHallucinogensSignal TransductionModels, MolecularReceptors, SerotoninDrug DevelopmentReceptor, Cannabinoid, CB1

Stichwörter der Autor:innen

GPCRcannabinoiddrugs of abuseopioidpharmacologyserotoninstructure

Substanzen

Analgesics, OpioidCannabinoidsHallucinogensReceptors, G-Protein-CoupledIllicit DrugsReceptors, SerotoninCNR1 protein, humanReceptor, Cannabinoid, CB1

Autor:innen und Institutionen

  • Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Electronic address: jmccorvy@mcw.edu.
  • Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:…

Förderung

  • NIGMS NIH HHS
  • NIDA NIH HHS
  • McKnight Foundation
  • Irma T Hirschl Trust
  • Monique Weill-Caulier Trust
  • Edward Mallinckrodt Jr Foundation
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Sanchez-Reyes, O. B., Zilberg, G., McCorvy, J. D., & Wacker, D. (2023). Molecular insights into GPCR mechanisms for drugs of abuse. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105176

Vancouver

Sanchez-Reyes OB, Zilberg G, McCorvy JD, Wacker D. Molecular insights into GPCR mechanisms for drugs of abuse. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105176

BibTeX
@article{SanchezReyes2023,
  author = {Sanchez-Reyes, Omar B and Zilberg, Gregory and McCorvy, John D and Wacker, Daniel},
  title = {Molecular insights into GPCR mechanisms for drugs of abuse},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105176}
}
Kostenlos starten →